Questioning the Safety and Benefits of Evolocumab

The Lancet Diabetes and Endocrinology - Netherlands
doi 10.1016/s2213-8587(17)30397-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Questioning the Safety and Benefits of Evolocumab – Authors' Reply

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Benefits of Industrial Safety in Productivity

International Journal of Advanced Engineering, Management and Science
2018English

Valuing the Benefits and Costs of Improved Food Safety and Nutrition

Australian Journal of Agricultural and Resource Economics
AgriculturalEconomicsEconometricsBiological Sciences
1998English

Benefits and Safety of Dietary Iodine Intake in India

Pakistan Journal of Nutrition
NutritionDieteticsPublic HealthFood ScienceEnvironmentalOccupational Health
2003English

RS13. Risk of Major Adverse Limb Events and Benefits of Evolocumab in Patients With Peripheral Artery Disease by History of Prior Peripheral Revascularization

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Efficacy of Evolocumab in Monogenic Versus Polygenic Hypercholesterolemia

CJC Open
Cardiovascular MedicineCardiology
2019English

Offsetting Behavior and the Benefits of Food Safety Policies in Vegetable Preparation and Consumption

Agribusiness
DevelopmentEconomicsCrop ScienceFood ScienceAnimal SciencePlanningZoologyAgronomyEconometricsGeography
2010English

The Safety and Feasibility of Transradial Cutting Balloon Angioplasty. Immediate Results, Benefits, and Limitations.

Japanese Heart Journal
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy